BackVerrica Pharmaceuticals Overview
Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Target Price

Analysts' 12-month price predictions for VRCA.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.81

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-12-18Loop Capital MarketsKemp Dolliver$17192.6% upsideOpen
2024-05-14JefferiesGlen Santangelo$12106.5% upsideOpen
2024-05-14H.C. WainwrightOren Livnat$14141% upsideOpen
2023-07-25NeedhamSerge Belanger$1072.1% upsideOpen